Drug Pipeline

Gilead will present new data on virologic suppression in adults 65 years and older at AIDS 2020: Virtual this week.

Five pharma markers are recalling the diabetes medication due to the presence of a carcinogenic ingredient.

Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.

Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.

Major depression drug recalled over wrong dosage.

Pfizer bucks the trend with as high as 98.5% price cuts.

Approval of Ubrelvy follows several new migraine drugs.

Here are the top drugs expected to be approved this year and their financial impact.

New HIV prevention drug not indicated for women.

From breast cancer to prostate cancer, the state of oncology care and how it will evolve.

What to expect for these high-dollar drugs.

The vaccines that could make a big impact on healthcare, from radical new flu vaccines to simplified meningococcal vaccine regimens.

The disease management and insurer initiatives changing the diabetes landscape.

The latest in RA therapies, and what you can expect from the pipeline.

Managed Healthcare Executive asked top experts their predictions for the top game-changing therapies. Here’s what they said.

The biggest drug categories and medications set for approval this year.

Major blockbuster drugs slated for launch in 2019 are expected to have a significant impact on treating certain cancers, diabetes, peanut allergies, and other conditions.

Vaccines are an important part of creating “herd immunity” to keep infectious diseases in check. Here are three vaccine developments that have far reaching implications for public health.

Gwen Nichols, MD, chief medical officer of the Leukemia & Lymphoma Society, offers a quick overview of current developments as well as a look forward.

Have two minutes? Listen to this quick podcast for critical takeaways from three of our top articles.

In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.

More targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.

Prepare for major pipeline developments in diabetes, autoimmune disorders, oncology, and COPD.

Autologous stem cell therapy may offer hope for patients with COPD. But some say caution is necessary.

CAR T-cell therapies and other immunotherapy give this oncologist’s cancer patients hope for a better quality of life.

Fluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.

Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.